Biosynth’s Acquisition of Celares

Gibson, Dunn & Crutcher LLP advised Biosynth in the transaction. Biosynth, a portfolio company of KKR, announced its acquisition of celares GmbH. The terms and conditions of the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

+Simple’s €90 Million Funding

Gibson, Dunn & Crutcher LLP acted for KKR Next Generation Technology on its growth investment in +Simple, assisted by Scotto Partners. McDermott represented Tikehau. Hogan Lovells...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Kiniciti’s Investment in Ncardia

AKD assisted Ncardia on the deal while Sidley Austin represented Kiniciti. Ncardia, a leader in developing stem cell-based solutions for drug discovery and cell therapy, secured more...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here